Webinars
Showing 1–12 of 22 results
Inherent donor variability of immune effector cells presents a significant challenge for developing a robust and reproducible ADCC assays for…
Read MoreIt is well established that ligand binding can protect proteins from thermal denaturation in a cellular milieu; however, the broad…
Read MoreProtein kinases are critical to many cellular pathways and play a role in several therapeutic areas such as oncology, inflammation,…
Read MoreThe screening and functional characterization of novel ligands for G-Protein Coupled Receptors (GPCR) remains a key focus in drug discovery.…
Read MoreThis 30-minute webinar shows you how to make your own cell-based assays to analyze β-arrestin recruitment in any cell type.…
Read MoreThe complex interactions between tumor cells and the host immune system are only beginning to be understood, however it is…
Read MoreKinase inhibitors often potently inhibit several off-target kinases in biochemical assays. Unfortunately, the relevance of these off-target interactions in a…
Read MoreOpioid receptors are among the most well-known GPCRs that regulate the transmission and perception of pain. Clinical management of severe…
Read MoreHere we will describe InCELL Pulse™, which uses DiscoverX’s Enzyme Fragment Complementation (EFC) technology to overcome these limitations of current…
Read MorePBMC effector cells have inherent donor variability, reducing their consistency and reproducibility in lot release assays. Antibody-Dependent Cell Cytotoxicity (ADCC)…
Read MoreGPCRs are privileged drug targets. Approximately 100 receptors still escape from the drug discovery process as they are orphans, without…
Read More